Baudax Bio Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Baudax Bio Inc 's ROA in the third quarter of 2023?
Baudax Bio Inc recorded a cumulative net loss of $-7 million during 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -53.82%.

However, within the Healthcare sector 655 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2023 quarter, so far to 4450, from total ROA ranking in the second quarter of 2023 at 5328.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Total Assets Change	1.12 %	-55 %	-85.53 %	-79.24 %	-71.53 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-7	-34	-35	-59	-23
Return On Assets (TTM)	-53.82 %	-259.9 %	-183.36 %	-200.68 %	-57.97 %
BXRX's Total Ranking	# 4450	# 5328	# 5403	# 6242	# 4951
Total Assets (TTM) in million	18	18	7	10	18
Seq. Total Assets Change	-3.65 %	160.11 %	-29.58 %	-42.71 %	-57.12 %
Seq. Net Income Change	-	-	-	-	-

BXRX's 5 Years Annual ROA >> Back to BXRX Management Effectiveness >> Compare BXRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 286
Sector	# 656
Overall	# 4372

Return On Assets Statistics
High	Average	Low
-20.13 %	-102.47 %	-246.24 %
(Jun 30 2022)		(Jun 30 2023)

Financial Statements
Baudax Bio Inc 's Assets	$ 18 million	BXRX's Balance sheet
Baudax Bio Inc 's Income	$ -2 million	Quarterly BXRX's Income Statement
BXRX's Income by Division		See BXRX's Income by Division

Annual Return On Assets	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	FY
Y / Y Total Assets Change	-81.17 %	-21.82 %	151.63 %	-	-
Total Assets in million	10	53	68	27	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-59	-22	-76	-33	0
Annual Return On Assets	-586.07 %	-41.65 %	-111.67 %	-120.21 %	-

BXRX's 5 Years Annual ROA >> Back to BXRX Management Effectiveness >> Compare BXRX ROA to its Competitors

More Return On Assets Ratios
BXRX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BXRX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BXRX's Competitors
Subscribers only: Roa for Baudax Bio Inc 's Suppliers
Subscribers only: Return On Assets for BXRX's Customers

You may also want to know
BXRX's Roi	BXRX's Inventory Turnover Ratio	BXRX's Growth Rates	BXRX's Dividend Comparisons
	BXRX's Profitability Ratios	BXRX's Asset Turnover Ratio	BXRX's Dividend Growth
BXRX's Roe	BXRX's Valuation Ratios	BXRX's Financial Strength Ratios	BXRX's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2023, within Healthcare Sector

ROA

Date modified: 2026-08-29T17:41:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.